We are live on ! Find out more
PM

Prosight Management Portfolio holdings

AUM $580M
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
-17.49%
1 Year Est. Return
+29.81%
3 Year Est. Return
+39.55%
5 Year Est. Return
-6.93%
10 Year Est. Return
–
AUM
$214M
AUM Growth
-$13.8M
Cap. Flow
+$50.8M
Cap. Flow %
23.74%
Top 10 Hldgs %
55.85%
Holding
56
New
18
Increased
15
Reduced
11
Closed
12

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$13.7M
2
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$7.82M
3
CUE icon
Cue Biopharma
CUE
+$6.7M
4
TZA icon
Direxion Daily Small Cap Bear 3x ETF
TZA
+$6.06M
5
ZGNX
Zogenix, Inc.
ZGNX
+$5.96M

Top Sells

Rank Stock Value
1
ARQL
Arqule Inc
ARQL
+$8.99M
2
UTHR icon
United Therapeutics
UTHR
+$6.39M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$6.02M
4
ZBH icon
Zimmer Biomet
ZBH
+$3.38M
5
NVST icon
Envista
NVST
+$2.74M

Sector Composition

Rank Sector Weight
1 Healthcare 90.8%
2 Miscellaneous 4.08%
3 Technology 2.61%
4 Energy 2.29%
5 Industrials 0.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRTK
51
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
– –
-450,000
Closed -$1.81M
MTEM
52
DELISTED
Molecular Templates, Inc.
MTEM
– –
-10,726
Closed -$2.25M
ARNA
53
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-142,400
Closed -$6.47M
TLGT
54
DELISTED
Teligent, Inc
TLGT
– –
-148,453
Closed -$632K
SBBP
55
DELISTED
Strongbridge Biopharma plc.
SBBP
– –
-1,258,224
Closed -$2.63M
ARQL
56
DELISTED
Arqule Inc
ARQL
– –
-450,326
Closed -$8.99M
1 2
3

Similar funds

SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
CCWM
Correct Capital Wealth Management Clayton, Missouri $580M AUM 16.45% 1-Year Est. Return
CMA
Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return
RIS
Retirement Income Solutions Ann Arbor, Michigan $581M AUM 19.42% 1-Year Est. Return
MFS
McNamara Financial Services Marshfield, Massachusetts $580M AUM 17.89% 1-Year Est. Return
GFI
Global Frontier Investments Charleston, South Carolina $581M AUM 8.55% 1-Year Est. Return
PWM
Praetorian Wealth Management Carmel, California $580M AUM 19.43% 1-Year Est. Return
CA
COFG Advisors Oak Brook, Illinois $579M AUM

Prosight Management's Q1 2020 Portfolio in Review

As of Q1 2020, Prosight Management held 56 positions worth $214M, down 6.1% from $228M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Prosight Management deployed $50.8M of net new capital in Q1 2020, opening 18 new positions and adding to 15 existing holdings. Its largest new stake was Alexion Pharmaceuticals: 140,000 shares worth $12.6M.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 94% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was United Therapeutics, an estimated $6.39M trimmed.

  • Prosight Management's largest Q1 2020 buy was Alexion Pharmaceuticals: 140,000 shares worth $12.6M.
  • Prosight Management added most to Cue Biopharma in Q1 2020, an estimated $6.7M increase.
  • Prosight Management's biggest Q1 2020 reduction was United Therapeutics, cutting an estimated $6.39M.
  • Prosight Management fully exited Arqule Inc in Q1 2020, selling an estimated $8.99M.
  • Prosight Management's ten largest holdings make up 56% of its $214M portfolio in Q1 2020.
  • Prosight Management opened 18 new positions and closed 12 in Q1 2020.
  • Prosight Management's portfolio value fell 6.1% quarter-over-quarter to $214M.

Based on Prosight Management's 13F filing for Q1 2020, filed 15 May 2020.